I don't. The only way they can possibly fund their trials is with dilution. I'm a full supporter of dilution and I see it as the only possibility of leronlimab ever getting an HIV PDUFA date. But guess what, they were supposed to move past this whole 'pre-revenue biotech' status in 2018.
Market Data 
Markets 
AI
